These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12452889)

  • 1. Pyogenic granuloma-like lesions during capecitabine therapy.
    Piguet V; Borradori L
    Br J Dermatol; 2002 Dec; 147(6):1270-2. PubMed ID: 12452889
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyogenic granuloma-like lesions caused by capecitabine therapy.
    Piqué-Duran E; Pérez-Díaz MJ; Pérez-Cejudo JA
    Clin Exp Dermatol; 2008 Aug; 33(5):652-3. PubMed ID: 18616732
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blisters unlike others].
    Gugerli O; Leupin N
    Rev Med Suisse; 2006 Apr; 2(62):1076-7. PubMed ID: 16711153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hand-foot syndrome with capecitabine therapy].
    Marini A; Hengge UR
    Hautarzt; 2007 Jun; 58(6):532-6. PubMed ID: 16897045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
    Risum S; Langer SW
    Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute cutaneous lupus erythematosus induced by capecitabine.
    Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
    Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
    [No Abstract]   [Full Text] [Related]  

  • 7. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
    Tavares-Bello R
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
    [No Abstract]   [Full Text] [Related]  

  • 8. Acral and palmo-plantar hyperpigmentation in a patient with disseminated hepatocellular carcinoma.
    Goyal R; Chalamalasetty SB; Madan K; Paul SB; Arora R; Safaya R; Acharya SK
    Indian J Gastroenterol; 2007; 26(6):292-3. PubMed ID: 18431015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxic dermatitis due to capecitabine: presentation of 2 cases and literature review].
    Gutiérrez-Pascual M; Sols-Candela M; Pinedo F; López-Estebaranz JL
    Actas Dermosifiliogr; 2009 May; 100(4):336-8. PubMed ID: 19463243
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of capecitabine-induced hand-foot syndrome by local phytotherapy].
    Kern E; Schmidinger M; Locker GJ; Kopp B
    Wien Med Wochenschr; 2007; 157(13-14):337-42. PubMed ID: 17704983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photosensitive lichenoid drug eruption to capecitabine.
    Walker G; Lane N; Parekh P
    J Am Acad Dermatol; 2014 Aug; 71(2):e52-3. PubMed ID: 25037814
    [No Abstract]   [Full Text] [Related]  

  • 12. [A woman with palmar and plantar hyperpigmentation].
    van Tienhoven G; Wilmink JW
    Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.
    Lee SD; Kim HJ; Hwang SJ; Kim YJ; Nam SH; Kim BS
    Korean J Intern Med; 2007 Jun; 22(2):109-12. PubMed ID: 17616027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
    Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
    Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome?
    Do JE; Kim YC
    Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer.
    Hague JS; Ilchyshyn A
    Clin Exp Dermatol; 2007 Jan; 32(1):102-3. PubMed ID: 16879449
    [No Abstract]   [Full Text] [Related]  

  • 17. A CDD polymorphism as predictor of capecitabine-induced hand-foot syndrome--letter.
    Ciccolini J; Evrard A; Lacarelle B
    Clin Cancer Res; 2012 Jan; 18(1):317. PubMed ID: 22215908
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyogenic granuloma possibly associated with capecitabine therapy.
    Fujiwara C; Motegi SI; Sekiguchi A; Amano H; Ishikawa O
    J Dermatol; 2017 Nov; 44(11):1329-1331. PubMed ID: 27864844
    [No Abstract]   [Full Text] [Related]  

  • 19. High frequency of hand foot syndrome with capecitabine.
    Kamil M; Haron M; Yosuff N; Khalid I; Azman N
    J Coll Physicians Surg Pak; 2010 Jun; 20(6):421-2. PubMed ID: 20642979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical henna for capecitabine induced hand-foot syndrome.
    Yucel I; Guzin G
    Invest New Drugs; 2008 Apr; 26(2):189-92. PubMed ID: 17885735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.